Global Clinical Trial Biorepository and Archiving Solutions Market Report and Forecast 2023-2031
Market Report I 2023-06-14 I 140 Pages I EMR Inc.
Global Clinical Trial Biorepository and Archiving Solutions Market Report and Forecast 2023-2031
Global Clinical Trial Biorepository and Archiving Solutions Market Outlook
The global clinical trial biorepository and archiving solutions market was valued at USD 3.91 billion in 2022, driven by the increasing complexity of clinical trials across the globe. The market size is anticipated to grow at a CAGR of 8.99% during the forecast period of 2023-2031 to achieve a value of USD 8.46 billion by 2031.
Introduction
Clinical trial biorepository and archiving solutions play a crucial role in the storage, management, and preservation of biological samples and associated data collected during clinical trials. These solutions ensure the integrity and traceability of samples, facilitating research and development of new therapies and treatments. This market introduction provides an overview of the clinical trial biorepository and archiving solutions market and highlights key trends shaping its growth.
The global market for clinical trial biorepository and archiving solutions is witnessing significant growth due to several factors. Firstly, the increasing number of clinical trials and the growing complexity of biomedical research have led to a surge in the volume of biological samples generated. Biorepositories provide the necessary infrastructure and expertise to store and manage these samples, ensuring their long-term preservation for future analysis.
Key Trends in the Clinical Trial Biorepository and Archiving Solutions Market
Key trends in the clinical trial biorepository and archiving solutions market include:
- Adoption of automation and robotics: The integration of automated systems and robotics in biorepositories has gained traction. These technologies streamline sample handling, storage, and retrieval processes, minimizing human errors and improving operational efficiency.
- Increasing use of cloud-based storage: Cloud-based storage solutions offer scalability, flexibility, and cost-effectiveness in managing large volumes of data generated from clinical trials. They provide secure and centralized access to data, facilitating collaboration and data sharing among researchers.
- Implementation of blockchain technology: Blockchain technology is being explored for enhancing data security, integrity, and traceability in biorepositories. It ensures transparency and immutability of data, providing a reliable and auditable record of sample custody, consent, and data access.
Clinical Trial Biorepository and Archiving Solutions Market Segmentations
Market Breakup by Products
- Preclinical Products
- Clinical Products
Market Breakup by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Market Breakup by Services
- Biorepository Services
- Archiving Services
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Clinical Trial Biorepository and Archiving Solutions Market Overview
The market for clinical trial biorepository and archiving solutions plays a crucial role in supporting biomedical research and drug development. Biorepositories serve as repositories for biological samples collected during clinical trials, storing them in a secure and controlled environment. These samples, including blood, tissue, and other biomaterials, provide valuable resources for researchers to study diseases, develop new therapies, and advance personalized medicine.
The demand for clinical trial biorepository and archiving solutions is driven by several factors. First, the increasing complexity of clinical trials and the growing need for precise biomarker analysis require efficient sample management and storage systems. Biorepositories provide the infrastructure and expertise to handle large volumes of samples and ensure their quality and integrity throughout the trial process.
Overall, the market for clinical trial biorepository and archiving solutions is poised for growth as the demand for high-quality samples, data integrity, and regulatory compliance continues to increase. Biorepositories that offer comprehensive solutions, incorporating advanced technologies and ensuring the highest standards of quality and security, will play a crucial role in advancing medical research and therapeutic development.
Clinical Trial Biorepository and Archiving Solutions Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Azenta U.S., Inc.
- Thermo Fisher Scientific Inc. (Patheon)
- Precision for Medicine, Inc.
- Medpace
- ATCC
- Q2 Solutions
- Labconnect
- Charles River Laboratories
- Cell&Co
- LabCorp Drug Development
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Clinical Trial Biorepository and Archiving Solutions Market Overview
3.1 Global Clinical Trial Biorepository and Archiving Solutions Market Historical Value (2016-2022)
3.2 Global Clinical Trial Biorepository and Archiving Solutions Market Forecast Value (2023-2031)
4 Global Clinical Trial Biorepository and Archiving Solutions Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter's Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Clinical Trial Biorepository and Archiving Solutions Market Segmentation
5.1 Global Clinical Trial Biorepository and Archiving Solutions Market by Products
5.1.1 Market Overview
5.1.2 Preclinical Products
5.1.3 Clinical Products
5.2 Global Clinical Trial Biorepository and Archiving Solutions Market by Phase
5.2.1 Market Overview
5.2.2 Phase I
5.2.3 Phase II
5.2.4 Phase III
5.2.5 Phase IV
5.3 Global Clinical Trial Biorepository and Archiving Solutions Market by Services
5.3.1 Market Overview
5.3.2 Biorepository Services
5.3.3 Archiving Servic es
5.3.4 Others
5.4 Global Clinical Trial Biorepository and Archiving Solutions Market by Region
5.4.1 Market Overview
5.4.2 North America
5.4.3 Europe
5.4.4 Asia Pacific
5.4.5 Latin America
5.4.6 Middle East and Africa
6 North America Clinical Trial Biorepository and Archiving Solutions Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Clinical Trial Biorepository and Archiving Solutions Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Clinical Trial Biorepository and Archiving Solutions Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Clinical Trial Biorepository and Archiving Solutions Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Clinical Trial Biorepository and Archiving Solutions Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.3 INDIA CDSCO
11.1.4 JAPAN PMDA
11.1.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Azenta U.S., Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Thermo Fisher Scientific Inc. (Patheon)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Precision for Medicine, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medpace
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 ATCC
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Q2 Solutions
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Labconnect
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Charles River Laboratories
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Cell&Co
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 LabCorp Drug Development
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.